Nomura Securities analyst M. Ian Somaiya lowered its price target on Infinity Pharmaceutical (NASDAQ: INFI) to $13.00 (from $17.00) while ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE